JASReference:Moriyama K:Sasaki J:Takada Y:Arakawa F:Matsunaga A:Ito Y:Arakawa K:,Biochim Biophys Acta,1996,1301,185: Difference between revisions
No edit summary |
mNo edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{JASReference|mutation= | {{JASReference|mutation= | ||
&&APOE/Mut/ | &&APOE/Mut/671/G-A&&R224Q&&exon4&&Mut/671/G-A&&R224Q (E2 Fukuoka)&&exon4 | ||
&& | |||
|title=Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis | |title=Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis | ||
|doi=10.1016/0005-2760(96)00014-8 | |doi=10.1016/0005-2760(96)00014-8 | ||
|pmid=8664327 | |pmid=8664327 | ||
}} | }} | ||
Latest revision as of 16:35, 7 June 2013
Details
NOTE: If you newly created/edited a reference page, please click all authors' links to check their information. If this reference contains an error, please use Template:IncorrectReference to report the discrepancy.
| IDs and Links | |
|---|---|
| Search | |
| Google Scholar | |
| Title | Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis |
| Author(s) | (Click a name to see records for each author.) |
| Journal | Biochimica et Biophysica Acta (9 pages) |
| Year | 1996 |
| Volume | 1301 |
| Page | 185 |
Genetic mutations in this article
| Reported Mutations (notation help) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||
How to input/edit information?
- Account Information
This database is maintained by the subcommittee for Lipid Metabolism in Japan Atherosclerosis Society. If you volunteer to contribute, please contact arita AT k.u-tokyo.ac.jp. |
このデータベースは日本動脈硬化学会 脂質代謝部会が作成しています。入力等に協力していただける方は有田 arita AT k.u-tokyo.ac.jp までご連絡下さい。 |
- Format of the page
The format of the page title is here. The format of mutation information is here. |